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ABSTRACT 
Neuropsychiatric symptoms like cognitive impairment and anxiety are prominent in the perimenopausal period and have been 
related to increased oxidative stress. Study evaluated effect of L-arginine on these neuropsychiatric symptoms and oxidative 
stress parameters. Immature female Sprague-Dawley rats were divided into 3 groups; Premenopausal injected with Corn-oil 
(2.5μl/g) for 15 days; VCD perimenopausal, injected with 4-vinylcyclohexene diepoxide (160mg/kg) diluted in Corn-oil for 15 
days; and AGING perimenopausal group. Fourteen weeks after VCD/corn-oil administrations, and 180 days in AGING 
perimenopausal group, rats were further divided into 2 sub-groups that received L-Arginine (100mg/kg) and distilled water for 
30 days. Thereafter, neurobehavioural assessments were carried out in animals at diestrus using Y-maze and elevated plus maze. 
Animals were humanely sacrificed, hippocampus and frontal lobe were isolated from the brain and homogenized for 
measurement of oxidative stress parameters. Percentage correct alternation was significantly higher (P< 0.05) in premenopausal 
compared to VCD and AGING perimenopausal groups. It was significantly lower (P < 0.05) in AGING perimenopausal group 
administered distilled water compared to AGING perimenopausal group administered L-Arginine with no change in other groups. 
Close Vs Open arm ratio was significantly lower (P < 0.05) in premenopausal compared to VCD and AGING perimenopausal 
groups. Similarly, L-Arginine significantly reduced (P < 0.05) Close Vs Open arm ratio in AGING PRM group while it 
significantly improved (P < 0.05) oxidative stress parameters in all groups. L-arginine improved cognition and anxiety in AGING 
perimenopausal with no change in premenopausal and VCD perimenopausal rats. 
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INTRODUCTION 
 
Cognitive impairment and anxiety related behaviours are 
commonly reported during the perimenopausal transitory 
period (Santoro et al., 2015, Muslic and Jokic-Begic, 2016). 
The perimenopausal transitory period is characterized by 
changes in the levels and function of reproductive hormones 
such as FSH, LH, oestrogen, progesterone, testosterone and 
dihydrotestosterone (Hale et al., 2014, Reis et al., 2014, 
Brinton et al., 2015, Santoro, 2016).  
 These changes are associated with increased oxidative 
stress which occur secondary to a marked increase in the 
production of reactive oxygen species. Increased oxidative 
stress in the perimenopausal period may account for the 
neurobehavioural symptoms seen during this transitory period 
(Joshi et al., 2015). This is because oxidative stress has been 
implicated in both cognitive dysfunction and anxiety disorders 
in the general population and recent studies have demonstrated 
the beneficial role of antioxidants in the management of these 
conditions ( de Oliveira et al., 2015, Zhao et al., 2017, Li et 
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al., 2018). Furthermore, a recent study showed that the 
antioxidant; melatonin improved psychosomatic symptoms in 
post-menopausal women (Chojnacki et al., 2018). These 
findings suggest that antioxidants may be beneficial in 
ameliorating the neuropsychiatric symptoms experienced in 
perimenopausal women.   
 L-arginine (L-ARG), is one of the commonly used 
antioxidant drugs. It is converted to nitric oxide (NO) by nitric 
oxide synthase (NOS) in the presence of heme and 
tetrahydrobiopterin as co-factors. Nitric oxide acts as both an 
antioxidant and a neurotransmitter and decreased NO 
transmission in the brain has been implicated in cognitive 
dysfunction (Zhu et al., 2017, Stephan et al., 2017).  It has 
been shown that drugs replacing NO levels are beneficial in 
disorders affecting memory and the ability of L-ARG to 
improve cognition has been attributed to its antioxidant 
potential as well as its neurotransmitter function (Fonar et al., 
2018).   
 A study demonstrated the protective effect of L-ARG on 
lipopolysaccharide induced memory deficit by improving 
oxidative stress parameters (Hosseini et al., 2018). While 
cognitive impairment is associated with low levels of NO, 
increased NO levels has been implicated in anxiety related 
disorders (Zhou et al., 2018). It has been shown that one of the 
mechanism of action of anxiolytic drugs is downregulating 
neuronal nitric oxide synthase (nNOS) and reducing NO 
levels (Zhou et al., 2018), although a few studies reported 
conflicting findings (Kalouda and Pitsikas, 2015, 
Trevlopoulou et al., 2016).  
 Low levels of NO and L-ARG has been reported in the 
perimenopausal period. A relatively lower plasma levels of L-
ARG in perimenopausal compared to premenopausal women 
has been reported (Klawitter et al., 2017). Studies in animal 
models of perimenopause has also demonstrated decreased 
levels of NOS activity and reduced NO production in the 
ovaries of perimenopausal rats (Zhao et al., 2012). Therefore, 
it appears that reduced levels of L-ARG may account for the 
changes associated with perimenopause and its replacement 
may be beneficial in the management of cognitive impairment. 
Thus, based on the antioxidant and NO increasing properties 
of L-ARG, we hypothesise that L-arginine supplementation 
will improve cognition with a variable effect on anxiety in 
perimenopausal animal models. 
 
 
MATERIALS AND METHODS 
 
Chemicals: 4-vinylcyclohexene diepoxide (VCD) was 
purchased from Sigma-Aldrich (St. Louis, MO, USA). L-
arginine was purchased from Nowfoods (USA). 
 
Experimental animals and diet: Thirty-six female Sprague-
Dawley rats were obtained from the animal laboratory center, 
College of Medicine, University of Lagos. All the animals 
were housed in groups of 6 rats per clear polypropylene cage 
lined with wood shavings. Rats were kept under normal light 
conditions (12 hours light/dark cycle) and normal room 
temperature (23 ± 1 °C). Pelletized normal rat chow and water 
was made available ad libitum, and all rats were weighed 
weekly. All experimental procedures were carried out in 
compliance with the international principles for laboratory 
animals as obtained in the Helsinki’s declaration (NIH 1985) 
guide for care and use of laboratory animals. The research 
protocol was also in line with the guidelines of the College of 
Medicine, University of Lagos, Health Research Ethics 
Committee. 
 
Experimental design and animal groupings: Twenty-four 
post-weaned female Sprague-Dawley rats at 28 days of age 
and twelve matured female Sprague-Dawley rats at 70 days of 
age were allowed to acclimatize for a week and the post-
weaned rats were randomly divided into 2 equal groups i.e. 
Premenopausal (PREMP) and VCD perimenopausal (VCD 
PRM) groups, while the matured rats served as the AGING 
perimenopausal (AGING PRM) group. The PREMP group 
received daily subcutaneous injection of corn oil (2.5 μl/g 
BW) for 15 consecutive days and allowed to grow till the 14th 
week. The VCD PRM group received daily subcutaneous 
injection of VCD (160 mg/Kg) (Mayer et al., 2004; Lohff et 
al., 2005) diluted in Corn oil (2.5 μl/g BW) for 15 consecutive 
days and also allowed to grow till the 14th week. The AGING 
PRM group was allowed to grow till 180 days of age.  
 Then all animals in the three groups were further 
subdivided into Distilled water (DW) and L-arginine (L-ARG) 
groups. L-arginine was administered via oral cannula at a dose 
of 100mg/kg in distilled water to rats in the L-ARG sub-
groups for additional duration of 4 weeks (Arikawe et al., 
2019), while distilled water only in equal volume as dissolved 
L-ARG was orally administered daily via oral cannula to rats 
in the DW sub-groups for additional duration of 4 weeks. The 
average age of rats in the PREMP and VCD PRM groups was 
160 days, while in the AGING PRM group was 210 days and 
14 weeks as stated above signified the number of weeks after 
either corn oil or VCD administration. We have previously 
observed that female rats injected with VCD subcutaneously 
usually transit towards reproductive senescence from 80 to 
100 days of age (yet to be published data). 
 At 150 – 165 days in PREMP and VCD PRM groups, and 
200 – 215 days in AGING PRM, vaginal smears were 
analyzed following the methods of Marcondes, Bianchi, and 
Tanno (Marcondes et al., 2002). Estrous cycle was monitored 
daily for 15 days consecutively and only rats showing regular 
estrous cyclicity were used. A regular estrous cycle was 
defined as a 4-day sequence of metestrus, diestrus, proestrus, 
and estrus.  
 Neurobehavioural assessments were carried out in the 
animals on diestrus morning using the Y maze and elevated 
plus maze (EPM). All the female rats were pre- exposed to the 
test battery a day before the tests and diestrus was determined 
by the predominance of small circular leukocytes, nucleated 
epithelial cells and non-nucleated cornified cells in vaginal 
smear under the microscope (Marcondes et al., 2002).   
 
Y-Maze test: The Y maze is used to measure locomotion 
activity and percentage correct alternation. The locomotion 
activity measures the complex neuronal circuit involved in 
movement and emotionality of the rats (Martin, 2003, Ramos, 
2008), while the proportion of correct alternation is a function 
of  working/spatial memory (Onaolapo and Onaolapo, 2013). 
The apparatus is a Y-shaped maze with three wooden arms 
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labelled A, B and C at a 120° angle from each other. The 
animals were allowed to freely explore the three arms for 4 
minutes, after introduction to the centre of the maze. An entry 
occurred when all four limbs are within the same arm. Correct 
alternation occurred when the rats entered the three arms 
sequentially. The number of arm entries and the number of 
correct alternation were recorded in order to calculate the 
percentage of alternation (Onaolapo and Onaolapo, 2013).  
 
Elevated Plus Maze : The elevated plus maze (EPM) is a 
validated model for testing anxiety related behaviour, 
preference for the closed arms suggests anxiety (Carobrez and 
Bertoglio, 2005). The EPM is a plus shaped maze with a 
central area and four arms; 2 open and 2 enclosed arms with a 
height of 50cm.  The central area is 10cm by 10cm in size 
while each arm is 50cm long and 10cm wide. The wall of the 
closed arms is 40 cm high. The animals were placed in the 
centre of the maze facing an open arm and were allowed to 
explore the maze for 4 min. Arm entry was recorded starting 
when two paws had crossed the line into the arm. The ratio of 
the time spent in the closed arm to open arm was then 
calculated.  
 
Brain tissue for oxidative stress assessment: The rats were 
humanely sacrificed by using a standard cervical dislocation 
procedure. The brains were quickly isolated with 
hippocampus and frontal lobe dissected from the whole brain, 
weighed, washed in ice-cold normal saline and homogenized 
in 10% ice-cold 0.1 M potassium phosphate buffer (pH 7.4). 
The  homogenates were centrifuged at 3000 RPM for 15 
minutes in a cold centrifuge with supernatants separated and 
stored at -70o C for the measurement of oxidative stress 
markers superoxide dismutase (SOD), malondialdehyde 
(MDA), reduced glutathione (GSH), and catalase as described 
in a previous study (Arora et al., 2010). 
 Glutathione level and glutathione peroxidase activity 
(GPx) were estimated using the method described by Ellman 
(Ellman, 1959). Catalase activity was determined by the 
colorimetric method as previously described (Clairborne, 
1985). Malondialdehyde was estimated using the method 
described by Ohkawa and co-workers (Ohkawa et al., 1979), 
and Superoxide dismutase activity was determined by the 
pyrogallol auto-oxidation method described by Marklund 
(Marklund, 1985). 
 
Statistical analysis: All results were expressed as mean ± 
S.E.M of rats 10 to 12 in each group. The data were 
statistically compared by carrying out One-way Analysis of 
Variance (ANOVA) using GraphPad Prism 8 followed by 
post-hoc Tukey’s test for inter-group comparisons. A value of 






Percentage correct alternation: The percentage correct 
alternation in female rats administered DW was significantly 
higher (P < 0.05) in the PREMP group compared to the VCD 
PRM and AGING PRM groups (Figure 1). Likewise, in the 
female Sprague-Dawley rats administered L-ARG, percentage 
correct alternation was significantly higher (P < 0.05) in the 
PREMP group compared to the VCD PRM and AGING PRM 
groups (Figure 1). However, in perimenopausal rats 
administered oral L-ARG, percentage correct alternation was 
significantly lower (P < 0.05) in the VCD PRM group 
compared to AGING PRM group (Figure 1).  Also, comparing 
the intra-groups, percentage correct alternation was 
significantly lower (P < 0.05) in the AGING PRM group 
administered DW compared to AGING PRM group 
administered L-ARG (Figure 1).  There was no significant 
difference in percentage correct alternation in VCD PRM DW 





Percentage Correct Alternation in PREMP, VCD PRM, and AGING 
PRM female rats 
*P < 0.05 Vs. PREMP Distilled water; αP < 0.05 PREMP L-ARG; 
βP < 0.05 AGING PRM L-ARG 
 
Elevated plus maze - Closed versus open arm entry ratio: 
The closed versus open arm ratio in female Sprague-Dawley 
rats administered DW was significantly higher (P < 0.05) in 
the perimenopausal (VCD PRM and AGING PRM) groups 
compared to the premenopausal (PREMP) group (Figure 2).  
Likewise, in perimenopausal rats administered L-ARG, closed 
versus open arm ratio was significantly higher (P < 0.05) in 
the VCD PRM group compared to the AGING PRM group 
(Figure 2). Also closed versus open arm ratio was significantly 
higher (P < 0.05) in the AGING PRM group administered DW 
compared to AGING PRM group administered L-ARG 
(Figure 2).  
 The closed versus open arm ratio in female Sprague-
Dawley rats administered DW was significantly higher (P < 
0.05) in the perimenopausal (VCD PRM and AGING PRM) 
groups compared to the premenopausal (PREMP) group 
(Figure 2).  Likewise, in perimenopausal rats administered L-
ARG, closed versus open arm ratio was significantly higher (P 
< 0.05) in the VCD PRM group compared to the AGING PRM 
group (Figure 2). Also closed versus open arm ratio was 
significantly higher (P < 0.05) in the AGING PRM group 
administered DW compared to AGING PRM group 
administered L-ARG (Figure 2).  
 
Oxidative stress parameters assessment in distilled water 
groups 
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Frontal lobe: In the frontal lobe in all animals that had 
distilled water, MDA level was significantly lower (p<0.05) 
in the AGING PRM DW group compared to the PREM DW 
group (Table 1). On the other hand, there was no significant 
change in GSH levels, the activity of CAT and SOD in the 
VCD PRM DW and AGING PRM DW groups compared to 




Ratio close Vs open arm in PREMP, VCD PRM, and AGING PRM 
female rats 
*P < 0.05 Vs. PREMP Distilled water; πP < 0.05 Vs VCD PRM L-
ARG; 
βP < 0.05 Vs AGING PRM L-ARG 
 
 
Hippocampus: In the hippocampus in all animals that had 
distilled water, there was no significant change in the activity 
of SOD. However, CAT activity was significantly higher 
(p<0.05) in the VCD PRM DW group compared to the PREM 
DW group (Table 2). On the other hand, there was no 
significant difference in the levels of GSH and MDA amongst 
the groups (Table 2). 
 
Effects of L-Arginine supplementation on oxidative stress 
parameters assessment 
 
Frontal Lobe: In the frontal lobe in all animals that had L-
ARG supplementation, there was a significant decrease 
(p<0.05) in the activity of SOD in the PREMP L-ARG group 
compared to the PREM DW group (Table 1). MDA level was 
also significantly lower (p<0.05) in all the L-ARG 
supplemented groups compared to the distilled water groups 
(Table 1).  
 
Hippocampus: In the hippocampus, L-Arginine 
supplementation significantly reduced (p<0.05) CAT activity 
in the VCD PRM L-ARG group compared to the VCD PRM 
DW group (Table 2). GSH level was significantly increased 
(p<0.05) in the PREMP L-ARG group compared to the PREM 
DW group. Likewise, GSH level was significantly increased 
(p<0.05) in the VCD PRM L-ARG group compared to the 





This study demonstrated the presence of cognitive impairment 
and anxiety related behaviour in animal models of 
perimenopause and is in consonance with previous studies 
(Reis et al., 2014, Santoro et al., 2015, Muslic and Jokic-
Begic, 2016). The perimenopausal (VCD PRM and AGING 
PRM) rats had impaired working memory, and this was 
demonstrated by a reduction in the proportion of correct 
alternation compared to premenopausal rats (PREMP group) 
as seen in Figure 1.
 
Table 1:  
Level and activity of oxidative stress parameters in the frontal lobe 
Frontal Lobe PREMP VCD PRM AGING PRM 
 DW L-ARG DW L-ARG DW L-ARG 
GSH Level (µmol/ml) 11.17 ± 0.61 9.24 ± 0.63 11.30 ± 0.64 9.66 ± 0.61 9.75 ± 0.87 9.19 ± 0.98 
MDA Level (µmol/ml) 0.62 ± 0.06 0.34 ± 0.07* 0.78 ± 0.11 0.15 ± 0.01δ 0.25 ± 0.02* 0.14 ± 0.02κ 
CAT Activity (µmol/ml/min/mg pro) 17.27 ± 1.77 14.35 ± 1.72 20.32 ± 2.49 24.07 ± 2.42 18.42 ± 1.21 20.72 ± 1.21 
SOD Activity (µmol/ml/min/mg pro) 4.00 ± 0.55 2.46 ± 0.14* 3.70 ± 0.54 4.33 ± 0.45 4.66 ± 0.25 4.97 ± 0.51 
Level and activity of oxidative parameters in the frontal lobe in PREMP, VCD PRM, and AGING PRM female rats. 
*P < 0.05 Vs. PREMP DW; δP < 0.05 Vs VCD PRM DW; κP < 0.05 Vs AGING PRM DW 
 
Table 2:  
Level and activity of oxidative stress parameters in the hippocampus 
Hippocampus PREMP VCD PRM AGING PRM 
 DW L-ARG DW L-ARG DW L-ARG 
GSH Level (µmol/ml) 10.70 ± 0.52 13.66 ± 0.53* 9.28 ± 0.29 11.97 ± 0.31δ 12.19 ± 0.95 10.98 ± 0.94 
MDA Level (µmol/ml) 0.34 ± 0.071 0.10 ± 0.070 0.59 ± 0.095 0.58 ± 0.083 0.29 ± 0.080 0.41 ± 0.087 
CAT Activity 
(µmol/ml/min/mg pro) 
16.10 ± 2.59 14.49 ± 2.65 31.11 ± 2.81* 15.24 ± 2.78δ 19.25 ± 0.80 18.24 ± 0.71 
SOD Activity 
(µmol/ml/min/mg pro) 
5.54 ± 0.92 3.57 ± 1.00 4.38 ± 0.29 3.98 ± 0.38 4.17 ± 0.55 5.47 ± 0.56 
Level and activity of oxidative parameters in the hippocampus in PREMP, VCD PRM, and AGING PRM female rats. 
*P < 0.05 Vs. PREMP DW; δP < 0.05 Vs VCD PRM DW 
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This is in line with previous documentations in 
perimenopausal women (Greendale et al., 2011).  Other 
studies on menopausal animal models have reported impaired 
cognition though there is paucity of data on animal 
perimenopausal models on cognition ( Patki et al., 2013, 
Djiogue et al., 2018). Likewise, the perimenopausal (VCD 
PRM and AGING PRM) rats showed a preference for the 
closed arm of the EPM rather than the open arm which 
supports increased anxiety (Carobrez and Bertoglio, 2005). 
Reis and colleagues had earlier reported a decrease in the rate 
of open arm exploration in VCD induced perimenopause in 
rats (Reis et al., 2014) and our results support this (Figure 2). 
 Our results also showed that the L-Arginine 
supplementation had variable effects on cognitive function 
and anxiety in the three groups. In the PREMP group, there 
was no significant difference in the measures of anxiety and 
memory between the DW and L-ARG groups. We have earlier 
reported the beneficial role of a similar dose of L-Arginine in 
reducing drug-induced cognitive impairment with no 
significant change in normal rats (Olusanya et al., 2018). 
Likewise, a study reported that the administration of L-
homoarginine, (a structural analogue of L-Arginine and NO 
precursor) to healthy humans without cognitive dysfunction 
showed no improvement in cognition (Schonhoff et al., 2018).  
These suggests that L-arginine may be more beneficial in 
cognitively impaired models rather than models without 
impaired cognition. 
 L-arginine also appears to follow this similar pattern of 
response as demonstrated above on cognition in non-anxious 
states. A study investigating the effect of administration of a 
combination of L-Arginine and dehydroepiandrostenedione (a 
neurosteroid) on anxiety, found a significant reduction in 
anxiety scores whereas there was no difference between the 
anxiety measurement in non-anxious rats (Chakraborti et al., 
2011).  
 In the AGING PRM rats, L-arginine administration 
significantly improved memory and reduced anxiety but had 
no effect on these parameters in the VCD PRM group. The 
beneficial effect of L-arginine and NO donors on cognition 
has been well documented (Fonar et al., 2018, Polis et al., 
2018) whereas the effect on anxiety is controversial (Gulati et 
al., 2017). The reason for the beneficial effect may be related 
to the low dose given. The dose given was probably enough to 
increase the deficient levels of NO in the brain but not 
sufficient to induce anxiety since reduced NOS activity and 
NO levels have been documented in the perimenopausal 
period in women (Klawitter et al., 2017), and perimenopausal 
animal model (Zhao et al., 2012).   
 L-Arginine supplementation had differential effects on 
cognition and anxiety in both animal models of 
perimenopause in this study. The difference may be related to 
the reproductive age of the animals and more importantly 
mechanism underlying perimenopausal induction since it has 
been reported that perimenopause as a transitory period is 
characterized by fluctuating levels of reproductive hormones 
to a more sustained reduction in the late phases and distinct 
biochemical changes from beginning to the end of the 
spectrum (Allshouse et al., 2018). Plausibly, the VCD PRM 
group represents the later phase of perimenopause compared 
to the AGING PRM group as shown from our results (Tables 
1 and 2). These findings support the view that severe oxidative 
changes develop as reproductive senescence progresses 
(Kolesnikova et al., 2015, Taleb-Belkadi et al., 2016), albeit 
because oxidative stress could be the primary cause of a 
disorder or occur secondary to the effect of a disorder (Sies, 
2015).  
 The increased oxidative stress reported in the VCD PRM 
group was more pronounced in the hippocampus compared to 
the frontal lobe (Tables 1 and 2). This could be linked to 
changes in neurotransmission in the hippocampus which have 
been implicated in both cognitive changes and anxiety 
disorders (Rio-Alamos et al., 2017). Disruption in 
neurotransmission in the limbic structure made up of 
hippocampus, amygdala, perirhinal, entorhinal cortex, and 
basal forebrain results in anxiety disorder. Coincidentally, 
nNOS is highly concentrated in similar regions of the brain 
mediating anxiety (Zhou et al., 2018). Thus, our results 
support a link between NO pathway and the development of 
anxiety and a pathological basis for the development of 
anxiety in the perimenopausal period. 
 The Y-maze measures working and spatial memory and 
can be employed as a measure of interaction between the 
prefrontal cortex and the hippocampus. Thus, disruption in 
working memory suggests involvement of the prefrontal 
cortex (Roberson et al., 2012). L-arginine supplementation 
improved oxidative stress parameters in both perimenopausal 
groups and this supports the antioxidant potentials of L-
arginine. However, the improved oxidative state did not 
translate into improved cognition or reduced anxiety in the 
VCD PRM group and this suggests an alternative mechanism 
of action of L-arginine since it has a pleotropic effect in the 
central nervous system. For example, apart from its role as an 
antioxidant, it is involved in neurotransmission, which is an 
essential component of memory formation, it also increases 
cerebral blood flow and maintains sleep-wake cycle  (Kajitani 
et al., 2010, Paul and Ekambaram, 2011, Virarkar et al., 2013).  
 Memory impairment and anxiety disorders as common 
comorbidities in perimenopause are both associated with 
oxidative stress but seems to be on opposite end of the 
spectrum when it comes to nitric oxide replacement (Wultsch 
et al., 2007). Thus, drugs targeting nitric oxide replacement 
during perimenopause need to be carefully titrated to avoid 
excessively high levels of NO. Likewise, the L-arginine 
supplementation may be a useful approach in the management 
of perimenopausal neuropsychiatric disorders as suggested in 
this study.  This is one of the few studies that have addressed 
the neuropsychiatric symptoms which are predominant during 
perimenopause. L-arginine supplementation improved 
oxidative stress, but it’s effect on memory and anxiety during 
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